Evidence map›Paper›PMID 29526964›Full record

ArticleInternal medicine (Tokyo, Japan)2018

Large Bowel Progressive Stricture after Infliximab Therapy for Crohn's Disease.

Katsunori Matsueda, Tatsuya Toyokawa, Masahiro Sakata, Isao Fujita, Jouichiro Horii

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Katsunori MatsuedaDepartment of Gastroenterology, National Hospital Organization Fukuyama Medical Center, Japan.
Tatsuya ToyokawaDepartment of Gastroenterology, National Hospital Organization Fukuyama Medical Center, Japan.
Masahiro SakataDepartment of Gastroenterology, National Hospital Organization Fukuyama Medical Center, Japan.
Isao FujitaDepartment of Gastroenterology, National Hospital Organization Fukuyama Medical Center, Japan.
Jouichiro HoriiDepartment of Gastroenterology, National Hospital Organization Fukuyama Medical Center, Japan.
National Hospital Organization · JPFukuyama Cardiovascular Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This case report refers to a 31-year-old patient with an 11-year history of Crohn's disease. The patient presented with an edematous elevated lesion in the splenic flexure. Two histological analyses revealed no signs of obvious dysplasia, and the patient subsequently began infliximab treatment. Nine months later, a worsening of the stricture of the edematous elevated lesion was observed in the splenic flexure, and transverse colonic resection was performed. A histological investigation of the lesion in the splenic flexure revealed advanced adenocarcinoma. Six months after the surgery, computed tomography revealed recurrent carcinoma and peritoneal metastases. The patient was administered palliative chemotherapy.

Indexed as

AdenocarcinomaAdultAntibodies, MonoclonalColonic NeoplasmsCrohn DiseaseHumansInfliximabMaleTomography, X-Ray ComputedAntibodies, MonoclonalInfliximabcolonic carcinomaCrohn's diseaseinfliximabTNFα blockade

Identifiers

PMID29526964
PMCPMC6120837
OpenAlexW2794025547

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.